MoonLake Immunotherapeutics

MLTX

18.5201.02% ( -0.190 )

Trading: Jul 29, 15:35:40 (EDT)

Financial report interval: 2025.12.31 - 2026.03.31

Preview: MoonLake Immunotherapeutics(MLTX) predict that the EBIT is -70.02 M (-47.47%), Miss estimate;the EPS is -0.98 (-55.56%), Miss estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

Revenue

TBA--

0.00B--

----

EBITMiss expectations

-0.07B47.47%

-0.07B38.84%

-0.00B8.63%

EPSMiss expectations

-0.9855.56%

-0.912944.90%

-0.067110.66%

ActualEstimateUnit: USD

ActualEstimateUnit: USD

ActualEstimateUnit: USD

ActualEstimateUnit: USD